Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
November 08, 2022 09:00 ET | InSilico Medicine
Abu Dhabi, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Insilico Medicine Signs Strategic Research Collaboration with Sanofi worth up to $1.2 Billion
November 08, 2022 09:00 ET | InSilico Medicine
New York, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical stage artificial intelligence (AI)-driven drug discovery company, announced a multi-year, multi-target strategic research...
Researchers Investigate Nature’s Smallest “Social Cheaters”
September 14, 2022 12:30 ET | Burroughs Wellcome Fund
Research Triangle Park, N.C., Sept. 14, 2022 (GLOBE NEWSWIRE) -- Being a member of a community often requires sacrifice. Species from across the animal kingdom have been shown to cooperate with...
PETVIVO HOLDINGS, INC. ANNOUNCES PARTICIPATION AT THE H.C. WAINWRIGHT GLOBAL INVESTMENT CONFERENCE SEPTEMBER 12-14, 2022
September 06, 2022 13:15 ET | PetVivo Holdings, Inc.
MINNEAPOLIS, Sept. 06, 2022 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) ("PetVivo"), an emerging biomedical device company focused on the commercialization of innovative...
UATG LOGO Jan. 16.jpg
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Eye Gel
August 02, 2022 08:30 ET | Umbra Applied Technologies Group, Inc.
Tampa, FL, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc. (OTC Pink UATG) ("UAT Group") announced today that its subsidiary, The Dreaming Company, is expanding on its...
UATG LOGO Jan. 16.jpg
UAT Group Subsidiary, The Dreaming Company Announces Hygieia Bedding Line
July 26, 2022 08:00 ET | Umbra Applied Technologies Group, Inc.
Tampa, FL, July 26, 2022 (GLOBE NEWSWIRE) -- Umbra Applied Technologies Group, Inc’s (OTC Pink: UATG) ("UAT Group"), announced today that its subsidiary, The Dreaming Company, is expanding on the...
Logo Biomedical.png
Institute of Biomedical Research Corp Announces Purchase of Biomedical and Nutraceutical Assets
July 22, 2022 06:00 ET | Institute of Biomedical Research Corp.
SEATTLE, WA, July 22, 2022 (GLOBE NEWSWIRE) -- Institute of Biomedical Research Corp. (OTC Pink: MRES), a diversified biomedical company, announces the purchase of biomedical and nutraceutical...
TIP_link_300x300.jpg
By 2028, Demand for Electrophysiology Market Size $14.84 Billion at 10.2% CAGR Lead by Atrial Fibrillation (11% CAGR in 2028) Global Analysis by The Insight Partners
June 20, 2022 07:01 ET | The Insight Partners
New York, June 20, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Electrophysiology Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
NeuroSigma.png
NeuroSigma Announces That a Team Led by UCLA Researchers Receives NIH Grant to Conduct a Multicenter Trial of eTNS for Pediatric ADHD
June 14, 2022 11:00 ET | NeuroSigma, Inc.
Double-blind randomized controlled trial will enroll up to 225 children at UCLA and Seattle Children’s Hospital NeuroSigma will provide Monarch eTNS Systems and funding for long-term follow-up ...
SPOM New Logo.png
SPO Global Inc. Discusses Company’s Medical Devices
June 08, 2022 09:00 ET | SPO Global Inc.
Shandong, China, June 08, 2022 (GLOBE NEWSWIRE) -- SPO Global Inc. (OTC PINK: SPOM), a healthcare and biotech company, today provides an in depth discussion of the company’s medical devices. ...